Hepatitis E seroprevalence and viremia rate in immunocompromised patients: A systematic review and meta-analysis
Abstract
BACKGROUND AND AIMS: Hepatitis E is an infectious disease of the liver caused by the hepatitis E virus (HEV). Immunocompromised patients present a particular risk group, as chronification of hepatitis E leading to life-threatening cirrhosis occurs when these patients are infected. Therefore, this study aims to estimate and compare the anti-HEV seroprevalence and the rate of HEV RNA positivity in transplant recipients and patients with human immunodeficiency virus (HIV). METHODS: This systematic review and meta-analysis involved a literature search (PubMed, Scopus; 1,138 studies) including 120 studies from 1
Authors
Buescher G, Ozga AK, Lorenz E, Pischke S, May J, Addo MM, Horvatits T
Year
2020
Topics
- Epidemiology and Determinants of Health
- Epidemiology
- Population(s)
- General HIV+ population
- General HIV- population
- Co-infections
- Other
